Stem Cells Market Size, Share & Trends Report

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application (Regenerative Medicine, Drug Discovery & Development), By Technology, Therapy, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-130-6
  • Number of Pages: 195
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2023
  • Industry: Healthcare
To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your research needs.

This website is secure and your personal details are safe.

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPA norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

GVR Report cover Stem Cells Market Size, Share & Trends Report

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application (Regenerative Medicine, Drug Discovery & Development), By Technology, Therapy, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-130-6
  • Number of Pages: 195
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2023
  • Industry: Healthcare

Stem Cells Market Size & Trends

The global stem cells market size was valued at USD 14.80 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 11.43% from 2024 to 2030. The growing development of precision medicine, increase in the number of cell therapy production facilities and rising number of clinical trials are expected to be major driving factors of the market. Recent advances in the stem cells therapeutics and the tissue engineering hold the potential to draw the attention for treatment of several diseases. Furthermore, increasing demand for stem cells banking and rise in research activities pertaining to stem cells production, storage, and characterization are also expected to fuel the revenue growth for the market. Technological improvements in the parent and ancillary market for stem cells usage are some of the other factors that reinforce the expected growth in demand for stem cells over the forecast period.

U.S. Stem Cells market size and growth rate, 2024 - 2030

The COVID-19 pandemic had a positive impact on the market. The application of the products in the treatment of the novel coronavirus has increased the interest of medical researchers, resulting in an increase in clinical trials. Regenerative medicine based on cellular therapies may be a treatment option for patients, resulting in a reduction in mortality and infection rates. Companies and research institutes are collaborating to develop novel treatment options for the disease. For example, Infectious Disease Research Institute and Celularity, announced in April 2020 that the US FDA had approved a clinical trial application to develop cell-based therapy for COVID-19. Hence, growing applications for clinical trials are expected to boost the demand for stem cells during the forecast period.

Moreover, researchers are increasingly attempting to develop stem cells therapies for targeting COVID-19. For instance, in January 2020, researchers from the University of Miami, administered two stem cells infusions in COVID-19 patients that were suffering from lung damage. The results concluded that there were no significant side effects, and the therapy was reliable. Growing demand for regenerative medicines is expected to fuel market growth. Regenerative medicines have extensive applications in treatment of various diseases including neurology, oncology, hepatology, diabetes, injuries, hematology, and orthopedics. In addition, growing geriatric population and increasing demand for regenerative medicines for early detection and prevention of diseases are some of the factors contributing to market growth.

Regenerative medicines help in restoring normal functioning of cells. Rapid advancements in this field is anticipated to provide effective therapies for chronic conditions. For instance, in March 2022, Wipro Ltd, and Pandorum Technologies, announced a long-term partnership. Together the companies plan to aim on the development of technologies that will reduce the time-to-market and boost the patient outcome during clinical trials and research and development of regenerative medicine. Biotech Pandorum will use Wipro’s AI facilities for the development of regenerative medicine and advanced therapeutics to enhance patient outcomes.

There is wide global anticipation for stem cell-based therapies as they are safe and effective. Stem cells are gaining attention for the development of regenerative medicine. Regenerative cell therapies have the potential for healing and replacing damaged tissues and organs. For these therapies, stem cells represent a great promising cell source and hence are receiving increasing attention from researchers, clinicians, and scientists. Several factors contribute to the market growth such as increasing collaborations, robust funding, government initiatives and extensive R&D. For instance, in May 2020, CiRA Foundation and CGT Catapult launched a new collaborative research project aimed on induced pluripotent stem cell characterization. The companies will combine their competence to investigate the novel methods to characterize pluripotent stem cells for the manufacturing of regenerative medicine products.

Significant R&D expenditures are one of the major contributors of market growth. Furthermore, another factor contributing to the increase is the increased need for effective therapeutics to reduce the disease burden during the forecast period. For instance, Celavie Biosciences' 5-year exploratory study on Parkinson's disease progressed in May 2020. The company is working on regenerative stem cell therapies to treat Parkinson's disease and other central nervous system disorders. Celavie Biosciences announced that their preliminary clinical trials utilizing OK99 stem cells for Parkinson's disease were successful.

Moreover, the increasing recognition of precision medicines is further promoting the market growth. Scientists are finding new procurement methods which can be further utilized for the development of personalized medicines. For instance, induced pluripotent stem cells therapies are developed by utilizing a small amount of sample from a patient’s skin or blood cell which is later on reprogrammed to form new tissue and cells for transplant. Moreover, in September 2022 Century Therapeutics and Bristol Myers Squibb announced a license agreement and research collaboration for the development and commercialization of iPSC-derived allogeneic cell therapies. Hence, with the application of these cells coupled with strategic activities by market players, potential personalized medicines can be developed in the near future

Market Concentration & Characteristics

The market growth stage is moderate, and pace of the market growth is accelerating. The market is expected to witness growth due to the increasing availability of variety of stem cell types such as mesenchymal stem cells, induced pluripotent stem cells, etc. for various research and development applications. Furthermore, intense competition in the market has led to highly competitive prices for high quality stem cell offerings.

Private 5G Network Market Concentration & Characteristics

Innovations in the market are improving the precision, scalability, and therapeutic potential of stem cells. Key innovative developments such as CRISPR-based gene editing are pushing the boundaries of stem cell-based therapies for various diseases, such as cancer, cardiovascular disease, etc. and represent a promising growth outlook for the market.

Mergers and acquisitions are contributing to the expansion of stem cells market and can lead to increase in adoption of research and development activities. For instance, in July 2022, Vertex Pharmaceuticals Incorporated acquired ViaCyte focusing on stem cell-derived cell replacement therapies.

Stringent guidelines govern research and clinical practices in the stem cell market and compliance with regulations may lead to additional procedural costs and increased research and development timelines which may restrict the market growth.

The market has moderate levels of product and regional expansion. Increase in market expansion pace has led to availability of stem cell technologies to local healthcare providers and researchers which has led to advancements in personalized medicine, tissue engineering, and therapeutic applications of stem cells. This factor is expected to boost the market growth in near future.

Product Insights

adult stem cells held the largest share of 76.36% of the market in 2023 as these cells do not involve the destruction of embryos, which is the case in embryonic stem cells. Furthermore, there is no risk of graft rejection in the case of adult stem cells. Development of cell banking services and advancements in bio preservation and cryopreservation are expected to further boost the demand for adult stem cells. Lesser ethical concerns surrounding adult cells further propel the growth of this segment. Benefits of adult stem cell banking such as capacity for autologous transformation, low risk of tumor formation, and availability of established treatment options are factors that expected to boost the growth of this segment during the forecast period.

Mesenchymal Stem Cells (MSCs), hematopoietic stem cells, epithelial/skin stem cells and neural stem cells, are all subtypes of ASCs. The MSC segment is expected to witness the fastest CAGR during the forecast period due to its use in autologous transplantation, substantial clinical trials which demonstrated its application for treating various diseases, and extensive ongoing research to investigate its therapeutic applications.

The induced pluripotent stem cells segment is expected to grow at the fastest CAGR of 18.22% during 2024 to 2030, owing to increased investment in developing regenerative medicines using induced pluripotent stem cells, ensured reproducibility and maintenance, ability to differentiate into all cell types, and high proliferative ability. Many leading companies are also expanding services related to iPSCs as their importance in the treatment of various diseases grows. For instance, in January 2021, REPROCELL launched a new personalized induced pluripotent stem cells production service for generating patient-specific iPSC. The service will assist in the preparation and storage of an individual's iPSCs for the development of regenerative medicines to treat future illnesses or injury. They are developed from mature cells using ready-to-use RNA reprogramming technology.

Application Insights

Regenerative medicine and drug discovery and development are two applications within the application segment. Increased approvals for clinical trials on stem cell therapies targeting various diseases has resulted in regenerative medicine segment capturing the larger market share of 90.17% in 2023. Longeveron LLC, for example, announced in June 2020 that Japan's Pharmaceutical and Medical Devices Agency (PMDA) had approved the start of Phase 2 clinical trial to evaluate the safety and efficacy of their mesenchymal stem cells that can be used to treat aging frailty.

Furthermore, several governments are heavily investing in the development of regenerative medicines. For instance, the Government of Canada invested around USD 6.9 million in regenerative medicine research in March 2020. This fund will be used to support nine translational projects and four clinical trials aimed at developing new therapies in the field of regenerative medicine. The developed regenerative medicines will aid in the treatment of a variety of blood disorders, heart diseases, diabetes, and vision loss.

The drug discovery and development segment is expected to grow at a faster CAGR from 2024-2030. As it is useful in studying human disease etiology, identifying pathological mechanisms, and developing therapeutic strategies for tackling various diseases, market products are seeing increased penetration across drug discovery process. Because they can mimic patients' molecular and cellular phenotypes, iPSC-based models are preferred over phenotypic screening. Pharmaceutical companies can use these to test hypothesized drug mechanisms in vitro in a cost-effective manner prior to conducting clinical trials.

Technology Insights

The cell acquisition segment captured the highest revenue share of 33.67% of the market in 2022. Discovery of embryonic stem cells has paved way for development of novel treatments for several diseases. These cells are pluripotent in nature and can be used to differentiate many cell types in the body. However, obtaining embryonic cells directly from the embryo has raised ethical concerns. Hence, researchers discovered an alternative—iPS cells. For instance, in September 2020, a collaborative team of researchers from Singapore and Australia studied the molecular changes, which occurs when adult skin cells become induced pluripotent stem cells (iPSCs). This led to the creation of new stem cells that could produce placenta tissue which could possibly lead to the development of new treatments for placenta complications arising during pregnancy.

The cell acquisition segment is further segmented into bone marrow harvest, umbilical blood cord and apheresis. The bone marrow harvest segment captured highest revenue share owing to the factors such as rising awareness, increasing prevalence of blood cancer, and easy access to bone marrow transplantation therapy.

Therapy Insights

Allogenic therapy segment captured the largest market share of 59.14% in 2023 with regards to revenue generation. Factors such as high pricing and growth in stem cell banking have contributed to the growth of this segment. Moreover, many cell therapy companies are shifting their business toward development of allogenic cell therapy products. This, in turn, is expected to result in the significant growth of this segment.

In addition, strategic activities by key market players to strengthen their product portfolio will further offer lucrative opportunities in the review period. For instance, In March 2021, Acepodia, announced the closing of its USD 47 million Series B financing to advance the pipeline of allogenic cell therapy candidates. In June 2022, Immatics and Bristol Myers Squibb expanded its strategic alliance for the development of gamma delta allogeneic cell therapy programs.

However, autologous therapy is expected to witness a lucrative rate throughout the forecast period. This is primarily due to low risk of complications associated with autologous treatment. Other factors anticipated to propel the growth of this segment include affordability, improved survival rate of patients, no need for identifying an HLA-matched donor, no risk of graft-versus-host diseases. Furthermore, autologous MSCs are investigated for their potential in the treatment of osteoarthritis as they can differentiate into cartilage and bone tissues.

MSCs have the ability to migrate to the site of injury, promote tissue repair by releasing anabolic cytokines, inhibit pro-inflammatory pathways, and differentiate into specialized connective tissues. Thus, adoption of autologous MSCs in regenerative medicine has increased, which is expected to propel the market growth during the forecast period.

End-user Insights

Pharmaceutical and biotechnology companies segment captured the largest market share of 53.76% in 2023. Some of the factors that can be attributed to the segment's share are rising prevalence of chronic disease, increase in clinical trials, upsurge in strategic activities along with improvements in healthcare services. For instance, in August 2022, StemCyte, Inc. obtained approval from U.S. FDA for their Phase II clinical trial for Post-COVID Syndrome using umbilical cord blood stem cell therapy. Moreover, in April 2022, US FDA granted clearance to BioCardia’s Investigational New Drug (IND) application to initiate a Phase I/II clinical trial of BCDA-04 in adults improving from acute respiratory distress syndrome linked with COVID-19.

Global Stem Cells market share and size, 2023

Moreover, increasing number of clinical trials coupled with approval of stem cell-based therapies from regulatory bodies will further offer lucrative opportunities. For instance, there are around 5,000 listed clinical trials involved in stem cells research on ClinicalTrials.gov, with new clinical trials being offered every day in this field.

Regional Insights

North America accounted for the largest revenue share of 43.56% in 2023. Presence of innovators and key market players has resulted into higher penetration of market products in the region. North America leads the market owing to strong biotechnology industry, presence of key players, extensive R&D and promotion of personalized medicines. The region accounts for the highest revenue share. Moreover, growth in this region can be further attributed to rising government initiative for promoting stem cell therapies. For instance, in March 2020, the government of Canada invested around USD 7 million in regenerative medicine and stem cell research. It will support 9 transnational projects and 4 clinical trials in the country for growing regenerative medicine sector.

Stem Cells Market Trends, by Region, 2024 - 2030

Asia Pacific is expected to grow at a rapid rate of 16.09% CAGR during 2024-2030 owing to strong product pipelines of therapies based on stem cells and a huge patient population base. Stem cells market is expected to grow at a rapid rate due to the increasing incidence rate of diseases such as cancer, neurological disorders, and diabetes. Moreover, government funding to accelerate research on stem cell further strengthens the growth of this region. For instance, In February 2022, the government of India has set up the state-of-the-art stem cell research facilities in 40 leading health research and educational institutions. The government has also spent USD 80 million through Indian Council of Medical Research (ICMR) in the last three years under certain research projects.

Key Companies & Market Share Insights

Key players in this market are developing new products and undertaking collaborative initiatives to increase their product portfolio, customer reach and geographic presence. These strategies are expected to favor the market growth in the coming years as more players enter the market and try to secure their market position.

Key Stem Cells Companies:

  • Thermo Fisher Scientific, Inc.
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • CellGenix GmbH
  • PromoCell GmbH
  • Takara Bio
  • Lonza
  • Cellartis AB
  • ATCC
  • AcceGen
  • Cell Applications, Inc.
  • Bio-Techne

Recent Developments

  • In October 2023, bit.bio, a company dedicated to programming human cells for innovative treatments, unveiled its latest product, ioCRISPR-Ready Cells. These cells are tailored for scientists aiming to create gene knockouts in human cells with physiological relevance.

  • In December 2023, the University of Texas at San Antonio (UTSA) and GenCure, a subsidiary of BioBridge Global, formalized their collaboration through the signing of a master services agreement. This agreement outlines their joint efforts in advancing the development of cellular therapy products, services, and testing.

  • In September 2023, SKAN Research Trust (SKAN) collaborated with the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) based in the UK. The partnership includes a joint research initiative focused on investigating the genomic patterns associated with age-related neurodegenerative diseases within an Indian cohort.

  • In July 2023, PromoCell announced the launch of the ‘PromoExQ MSC Growth Medium XF’ for cell therapy manufacturing applications. The xeno- and serum-free medium is compliant with the company’s EXCiPACT GMP certification scheme and has been optimized for in-vitro expansion of human MSCs in GMP regulated environment, offering consistent growth and maintenance of various types of multipotent MSCs

  • In April 2023, Gamida Cell announced that its allogeneic cell therapy, Omisirge (omidubicel-onlv), had received approval from the U.S. FDA for use in adult & pediatric patients aged 12 years and above facing hematologic malignancies. The therapy has received approval based on a global and randomized Phase 3 clinical study, making it the first allogeneic stem cell transplant therapy to do so.

  • In March 2023, Cellular Engineering Technologies (CET) announced that it had received exclusive approval for using immortalized human stem cells from the John Paul II Medical Research Institute. These stem cells were developed through the gene editing of human stem cells for producing next-generation human cells that have more native PTM than the existing cell lines deployed currently in bio-production applications. The exclusivity gives CET a strong chance to address various financial and scientific challenges related to iPSC-dependent cell replacement therapy

  • In January 2023, BrainStorm Cell Therapeutics announced that it would be donating biospecimens from NurOwn's placebo-controlled Phase 3 ALS trial to the Northeast Amyotrophic Lateral Sclerosis Consortium biorepository for use in the research community. The specimens submitted include serum and cerebrospinal fluid (CSF) samples that have been collected from participants in the trial treated with placebo

Stem Cells Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 16.50 billion

Revenue forecast in 2030

USD 31.56 billion

Growth rate

CAGR of 11.43% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD million and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, technology, therapy, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Thermo Fisher Scientific, Inc.; STEMCELL Technologies Inc.; Merck KGaA; CellGenix GmbH; PromoCell GmbH; Takara Bio; Lonza; Cellartis AB; ATCC; AcceGen; Cell Applications, Inc.; Bio-Techne

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional and segment scope.

Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Stem Cells Market Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the stem cells market on the basis of product, application, technology, therapy, end user, and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Adult Stem Cells (ASCs)

      • Hematopoietic

      • Mesenchymal

      • Neural

      • Epithelial/Skin

      • Others

    • Human Embryonic Stem Cells (HESCs)

    • Induced Pluripotent Stem Cells (iPSCs)

    • Very Small Embryonic Like Stem Cells

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Regenerative Medicine

      • Neurology

      • Orthopedics

      • Oncology

      • Hematology

      • Cardiovascular and Myocardial Infraction

      • Injuries

      • Diabetes

      • Liver Disorder

      • Incontinence

      • Others

    • Drug Discovery And Development

  • Technology Outlook (Revenue, USD Million, 2018 - 2030)

    • Cell Acquisition

      • Bone Marrow Harvest

      • Umbilical Blood Cord

      • Apheresis

    • Cell Production

      • Therapeutic Cloning

      • In-vitro Fertilization

      • Cell Culture

      • Isolation

    • Cryopreservation

    • Expansion And Sub-Culture

  • Therapy Outlook (Revenue, USD Million, 2018 - 2030)

    • Autologous

    • Allogenic

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Pharmaceutical & Biotechnology Companies

    • Hospitals & Cell Banks

    • Academic & Research Institutes

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1 Stem Cells Market: Research Technologyology
                   1.1. Market Segmentation & Scope
                       1.1.1. Product Segment
                       1.1.2. Application Segment
                       1.1.3. Technology Segment
                       1.1.4. Therapy Segment
                       1.1.5. End-use Segment
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased Database
                       1.3.2. GVR’s Internal Database
                       1.3.3. Secondary Sources
                       1.3.4. Primary Research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List Of Secondary Sources
                   1.8. List Of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2 Stem Cells Market: Market Definitions
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3 Stem Cells Market: Executive Summary
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Ongoing Developments In Regenerative Medicine
                           3.2.1.2. Rising Funds For Accelerating Stem Cell Research
                           3.2.1.3. Growing Demand For Stem Cell Banking
                           3.2.1.4. Increasing Prevalence Of Genetic Disorders
                       3.2.2. Market Restraint And Challenges Analysis
                           3.2.2.1. Ethical Concern Related To Stem Cell Research
                           3.2.2.2. Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
                   3.3. Industry Analysis Tools
                       3.3.1. Porter’s Five Forces Analysis
                       3.3.2. PESTEL Analysis
                       3.3.3. COVID-19 Impact Analysis
Chapter 4 Global Stem Cells Market Market Variables, Trends, & Scope
                   4.1. Stem Cells Market: Product Movement Analysis
                   4.2. Adult Stem Cells (ASCs)
                       4.2.1. Adult Stem Cells (ASCs) Market, 2018 - 2030 (USD Billion)
                       4.2.2. Hematopoietic
                           4.2.2.1. Hematopoietic Market, 2018 - 2030 (USD Billion)
                       4.2.3. Mesenchymal
                           4.2.3.1. Mesenchymal Market, 2018 - 2030 (USD Billion)
                       4.2.4. Neural
                           4.2.4.1. Neural Market, 2018 - 2030 (USD Billion)
                       4.2.5. Epithelial/Skin
                           4.2.5.1. Epithelial/Skin Market, 2018 - 2030 (USD Billion)
                       4.2.6. Others
                           4.2.6.1. Others Market, 2018 - 2030 (USD Billion)
                   4.3. Human Embryonic Stem Cells (HESCs)
                       4.3.1. Human Embryonic Stem Cells (HESCs) Market, 2018 - 2030 (USD Billion)
                   4.4. Induced Pluripotent Stem Cells (iPSCs)
                       4.4.1. Induced Pluripotent Stem Cells (iPSCs) Market, 2018 - 2030 (USD Billion)
                   4.5. Very Small Embryonic Like Stem Cells
                       4.5.1. Very Small Embryonic Like Stem Cells Market, 2018 - 2030 (USD Billion)
Chapter 5 Stem Cells Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
                   5.1. Stem Cells Market: Application Movement Analysis
                   5.2. Regenerative Medicine
                       5.2.1. Regenerative Medicine Market, 2018 - 2030 (USD Billion)
                       5.2.2. Neurology
                           5.2.2.1. Neurology Market, 2018 - 2030 (USD Billion)
                       5.2.3. Orthopedics
                           5.2.3.1. Orthopedics Market, 2018 - 2030 (USD Billion)
                       5.2.4. Oncology
                           5.2.4.1. Oncology Market, 2018 - 2030 (USD Billion)
                       5.2.5. Hematology
                           5.2.5.1. Hematology Market, 2018 - 2030 (USD Billion)
                       5.2.6. Cardiovascular and Myocardial Infraction
                           5.2.6.1. Cardiovascular and Myocardial Infraction Market, 2018 - 2030 (USD Billion)
                       5.2.7. Injuries
                           5.2.7.1. Injuries Market, 2018 - 2030 (USD Billion)
                       5.2.8. Diabetes
                           5.2.8.1. Diabetes Market, 2018 - 2030 (USD Billion)
                       5.2.9. Liver Disorder
                           5.2.9.1. Liver Disorder Market, 2018 - 2030 (USD Billion)
                       5.2.10. Incontinence
                           5.2.10.1. Incontinence Market, 2018 - 2030 (USD Billion)
                       5.2.11. Others
                           5.2.11.1. Others Market, 2018 - 2030 (USD Billion)
                   5.3. Drug Discovery and Development
                       5.3.1. Drug Discovery and Development Market, 2018 - 2030 (USD Billion)
Chapter 6 Stem Cells Market- Segment Analysis, by Application, 2018 - 2030 (USD Million)
                   6.1. Stem Cells Market: Technology Movement Analysis
                   6.2. Cell Acquisition
                       6.2.1. Cell Acquisition Market, 2018 - 2030 (USD Billion)
                       6.2.2. Bone Marrow Harvest
                           6.2.2.1. Bone Marrow Harvest Market, 2018 - 2030 (USD Billion)
                       6.2.3. Umbilical Blood Cord
                           6.2.3.1. Umbilical Blood Cord Market, 2018 - 2030 (USD Billion)
                       6.2.4. Apheresis
                           6.2.4.1. Apheresis Market, 2018 - 2030 (USD Billion)
                   6.3. Cell Production
                       6.3.1. Cell Production Market, 2018 - 2030 (USD Billion)
                       6.3.2. Therapeutic Cloning
                           6.3.2.1. Therapeutic Cloning Market, 2018 - 2030 (USD Billion)
                       6.3.3. In-vitro Fertilization
                           6.3.3.1. In-vitro Fertilization Market, 2018 - 2030 (USD Billion)
                       6.3.4. Cell Culture
                           6.3.4.1. Cell Culture Market, 2018 - 2030 (USD Billion)
                       6.3.5. Isolation
                           6.3.5.1. Isolation Market, 2018 - 2030 (USD Billion)
                   6.4. Cryopreservation
                       6.4.1. Cryopreservation Market, 2018 - 2030 (USD Billion)
                   6.5. Expansion and Sub-Culture
                       6.5.1. Expansion and Sub-Culture Market, 2018 - 2030 (USD Billion)
Chapter 7 Stem Cells Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)
                   7.1. Stem Cells Market: Therapy Movement Analysis
                   7.2. Autologous
                       7.2.1. Autologous Market, 2018 - 2030 (USD Billion)
                   7.3. Allogeneic
                       7.3.1. Allogeneic Market, 2018 - 2030 (USD Billion)
Chapter 8 Stem Cells Market - Segment Analysis, by Therapy, 2018 - 2030 (USD Million)
                   8.1. Stem Cells Market: Application Movement Analysis
                   8.2. Infectious Diseases
                       8.2.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
                   8.3. Immunology
                       8.3.1. Immunology Market, 2018 - 2030 (USD Billion)
                   8.4. Oncology
                       8.4.1. Oncology Market, 2018 - 2030 (USD Billion)
                   8.5. Stem Cells
                       8.5.1. Stem Cells Market, 2018 - 2030 (USD Billion)
                   8.6. Neurobiology
                       8.6.1. Neurobiology Market, 2018 - 2030 (USD Billion)
                   8.7. Others
                       8.7.1. Other Applications Market, 2018 - 2030 (USD Billion)
Chapter 9 Stem Cells Market - Segment Analysis, by End-User, 2018 - 2030 (USD Million)
                   9.1. Stem Cells Market: End-use Movement Analysis
                   9.2. Pharmaceutical and Biotechnology Companies
                       9.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Billion)
                   9.3. Hospitals & Cell Banks
                       9.3.1. Hospitals & Cell Banks Market, 2018 - 2030 (USD Billion)
                   9.4. Academic & Research Institutes
                       9.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Billion)
Chapter 10 Regional Business Analysis
                   10.1. Stem Cells Market Share By Region, 2023 & 2030
                   10.2. North America
                       10.2.1. North America Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.2.2. U.S.
                           10.2.2.1. Key Country Dynamics
                           10.2.2.2. Target Disease Prevalence
                           10.2.2.3. Competitive Scenario
                           10.2.2.4. U.S. Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.2.3. Canada
                           10.2.3.1. Key Country Dynamics
                           10.2.3.2. Target Disease Prevalence
                           10.2.3.3. Competitive Scenario
                           10.2.3.4. Canada Stem Cells Market, 2018 - 2030 (USD Billion)
                   10.3. Europe
                       10.3.1. Europe Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.2. UK
                           10.3.2.1. Key Country Dynamics
                           10.3.2.2. Target Disease Prevalence
                           10.3.2.3. Competitive Scenario
                           10.3.2.4. UK Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.3. Germany
                           10.3.3.1. Key Country Dynamics
                           10.3.3.2. Target Disease Prevalence
                           10.3.3.3. Competitive Scenario
                           10.3.3.4. Germany Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.4. France
                           10.3.4.1. Key Country Dynamics
                           10.3.4.2. Target Disease Prevalence
                           10.3.4.3. Competitive Scenario
                           10.3.4.4. France Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.5. Italy
                           10.3.5.1. Key Country Dynamics
                           10.3.5.2. Target Disease Prevalence
                           10.3.5.3. Competitive Scenario
                           10.3.5.4. Italy Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.6. Spain
                           10.3.6.1. Key Country Dynamics
                           10.3.6.2. Target Disease Prevalence
                           10.3.6.3. Competitive Scenario
                           10.3.6.4. Spain Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.7. Denmark
                           10.3.7.1. Key Country Dynamics
                           10.3.7.2. Target Disease Prevalence
                           10.3.7.3. Competitive Scenario
                           10.3.7.4. Denmark Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.8. Sweden
                           10.3.8.1. Key Country Dynamics
                           10.3.8.2. Target Disease Prevalence
                           10.3.8.3. Competitive Scenario
                           10.3.8.4. Sweden Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.3.9. Norway
                           10.3.9.1. Key Country Dynamics
                           10.3.9.2. Target Disease Prevalence
                           10.3.9.3. Competitive Scenario
                           10.3.9.4. Norway Stem Cells Market, 2018 - 2030 (USD Billion)
                   10.4. Asia Pacific
                       10.4.1. Asia Pacific Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.4.2. Japan
                           10.4.2.1. Key Country Dynamics
                           10.4.2.2. Target Disease Prevalence
                           10.4.2.3. Competitive Scenario
                           10.4.2.4. Japan Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.4.3. China
                           10.4.3.1. Key Country Dynamics
                           10.4.3.2. Target Disease Prevalence
                           10.4.3.3. Competitive Scenario
                           10.4.3.4. China Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.4.4. India
                           10.4.4.1. Key Country Dynamics
                           10.4.4.2. Target Disease Prevalence
                           10.4.4.3. Competitive Scenario
                           10.4.4.4. India Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.4.5. Australia
                           10.4.5.1. Key Country Dynamics
                           10.4.5.2. Target Disease Prevalence
                           10.4.5.3. Competitive Scenario
                           10.4.5.4. Australia Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.4.6. Thailand
                           10.4.6.1. Key Country Dynamics
                           10.4.6.2. Target Disease Prevalence
                           10.4.6.3. Competitive Scenario
                           10.4.6.4. Thailand Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.4.7. South Korea
                           10.4.7.1. Key Country Dynamics
                           10.4.7.2. Target Disease Prevalence
                           10.4.7.3. Competitive Scenario
                           10.4.7.4. South Korea Stem Cells Market, 2018 - 2030 (USD Billion)
                   10.5. Latin America
                       10.5.1. Latin America Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.5.2. Brazil
                           10.5.2.1. Key Country Dynamics
                           10.5.2.2. Target Disease Prevalence
                           10.5.2.3. Competitive Scenario
                           10.5.2.4. Brazil Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.5.3. Mexico
                           10.5.3.1. Key Country Dynamics
                           10.5.3.2. Target Disease Prevalence
                           10.5.3.3. Competitive Scenario
                           10.5.3.4. Mexico Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.5.4. Argentina
                           10.5.4.1. Key Country Dynamics
                           10.5.4.2. Target Disease Prevalence
                           10.5.4.3. Competitive Scenario
                           10.5.4.4. Argentina Stem Cells Market, 2018 - 2030 (USD Billion)
                   10.6. MEA
                       10.6.1. MEA Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.6.2. South Africa
                           10.6.2.1. Key Country Dynamics
                           10.6.2.2. Target Disease Prevalence
                           10.6.2.3. Competitive Scenario
                           10.6.2.4. South Africa Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.6.3. Saudi Arabia
                           10.6.3.1. Key Country Dynamics
                           10.6.3.2. Target Disease Prevalence
                           10.6.3.3. Competitive Scenario
                           10.6.3.4. Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.6.4. UAE
                           10.6.4.1. Key Country Dynamics
                           10.6.4.2. Target Disease Prevalence
                           10.6.4.3. Competitive Scenario
                           10.6.4.4. UAE Stem Cells Market, 2018 - 2030 (USD Billion)
                       10.6.5. Kuwait
                           10.6.5.1. Key Country Dynamics
                           10.6.5.2. Target Disease Prevalence
                           10.6.5.3. Competitive Scenario
                           10.6.5.4. Kuwait Stem Cells Market, 2018 - 2030 (USD Billion)
Chapter 11. Competitive Landscape
                   11.1. Company Categorization
                   11.2. Strategy Mapping
                   11.3. Company Market Share Analysis, 2023
                   11.4. Company Profiles/Listing
                       11.4.1. Thermo Fisher Scientific, Inc.
                           11.4.1.1. Overview
                           11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.1.3. Product Benchmarking
                           11.4.1.4. Strategic Initiatives
                       11.4.2. STEMCELL Technologies Inc.
                           11.4.2.1. Overview
                           11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.2.3. Product Benchmarking
                           11.4.2.4. Strategic Initiatives
                       11.4.3. Merck KGaA
                           11.4.3.1. Overview
                           11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.3.3. Product Benchmarking
                           11.4.3.4. Strategic Initiatives
                       11.4.4. CellGenix GmbH
                           11.4.4.1. Overview
                           11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.4.3. Product Benchmarking
                           11.4.4.4. Strategic Initiatives
                       11.4.5. PromoCell GmbH
                           11.4.5.1. Overview
                           11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.5.3. Product Benchmarking
                           11.4.5.4. Strategic Initiatives
                       11.4.6. Takara Bio
                           11.4.6.1. Overview
                           11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.6.3. Product Benchmarking
                           11.4.6.4. Strategic Initiatives
                       11.4.7. Lonza
                           11.4.7.1. Overview
                           11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.7.3. Product Benchmarking
                           11.4.7.4. Strategic Initiatives
                       11.4.8. Cellartis AB
                           11.4.8.1. Overview
                           11.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.8.3. Product Benchmarking
                           11.4.8.4. Strategic Initiatives
                       11.4.9. ATCC
                           11.4.9.1. Overview
                           11.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.9.3. Product Benchmarking
                           11.4.9.4. Strategic Initiatives
                       11.4.10. AcceGen
                           11.4.10.1. Overview
                           11.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.10.3. Product Benchmarking
                           11.4.10.4. Strategic Initiatives
                       11.4.11. Cell Applications, Inc.
                           11.4.11.1. Overview
                           11.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.11.3. Product Benchmarking
                           11.4.11.4. Strategic Initiatives
                       11.4.12. Bio-Techne
                           11.4.12.1. Overview
                           11.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           11.4.12.3. Product Benchmarking
                           11.4.12.4. Strategic Initiatives

 


List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 7 Global Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 8 Global Stem Cells Market, by Region, 2018-2030, (USD Million)
TABLE 9 North America Stem Cells Market, by Country, 2018-2030, (USD Million)
TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 14 North America Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 19 U.S. Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 20 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 21 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 22 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 23 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 24 Canada Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 25 Europe Stem Cells Market, by Country, 2018-2030, (USD Million)
TABLE 26 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 27 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 28 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 29 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 30 Europe Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 31 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 32 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 33 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 34 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 35 Germany Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 36 UK Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 37 UK Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 38 UK Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 39 UK Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 40 UK Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 41 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 42 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 43 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 44 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 45 France Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 46 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 47 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 48 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 49 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 50 Italy Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 51 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 52 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 53 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 54 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 55 Spain Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 56 Denmark Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 57 Denmark Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 58 Denmark Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 59 Denmark Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 60 Denmark Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 61 Sweden Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 62 Sweden Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 63 Sweden Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 64 Sweden Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 65 Sweden Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 66 Norway Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 67 Norway Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 68 Norway Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 69 Norway Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 70 Norway Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 71 Asia Pacific Stem Cells Market, by Country, 2018-2030, (USD Million)
TABLE 72 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 73 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 74 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 75 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 76 Asia Pacific Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 77 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 78 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 79 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 80 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 81 China Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 82 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 83 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 84 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 85 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 86 Japan Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 87 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 88 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 89 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 90 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 91 India Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 92 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 93 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 94 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 95 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 96 South Korea Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 97 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 98 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 99 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 100 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 101 Australia Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 102 Thailand Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 103 Thailand Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 104 Thailand Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 105 Thailand Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 106 Thailand Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 107 Latin America Stem Cells Market, by Country, 2018-2030, (USD Million)
TABLE 108 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 109 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 110 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 111 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 112 Latin America Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 113 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 114 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 115 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 116 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 117 Brazil Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 118 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 119 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 120 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 121 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 122 Mexico Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 123 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 124 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 125 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 126 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 127 Argentina Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 128 Middle East & Africa Stem Cells Market, by Country, 2018-2030, (USD Million)
TABLE 129 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 130 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 131 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 132 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 133 Middle East & Africa Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 134 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 135 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 136 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 137 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 138 South Africa Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 139 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 140 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 141 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 142 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 143 Saudi Arabia Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 144 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 145 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 146 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 147 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 148 UAE Stem Cells Market, by End-use, 2018-2030, (USD Million)
TABLE 149 Kuwait Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 150 Kuwait Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 151 Kuwait Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 152 Kuwait Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 153 Kuwait Stem Cells Market, by End-use, 2018-2030, (USD Million) 


List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Stem Cells Market Segmentation
FIG. 8 Market Snapshot, 2023
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 PESTEL Analysis
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Global Stem Cells Market: Product Movement Analysis
FIG. 15 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
FIG. 16 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
FIG. 17 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
FIG. 18 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
FIG. 19 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
FIG. 20 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
FIG. 21 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
FIG. 22 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
FIG. 23 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
FIG. 24 Global Stem Cells Market: Application Movement Analysis
FIG. 25 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
FIG. 26 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
FIG. 27 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
FIG. 28 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
FIG. 29 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
FIG. 30 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
FIG. 31 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
FIG. 32 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
FIG. 33 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
FIG. 34 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
FIG. 35 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
FIG. 36 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
FIG. 37 Global Stem Cells Market: Technology Movement Analysis
FIG. 38 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
FIG. 39 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
FIG. 40 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
FIG. 41 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
FIG. 42 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
FIG. 43 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
FIG. 44 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
FIG. 45 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
FIG. 46 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
FIG. 47 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
FIG. 48 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
FIG. 49 Global Stem Cells Market: Therapy Movement Analysis
FIG. 50 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
FIG. 51 Global Stem Cells Market, for Allogeneic, 2018 - 2030 (USD Million)
FIG. 52 Global Stem Cells Market, End-User Movement Analysis
FIG. 53 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
FIG. 54 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
FIG. 55 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
FIG. 56 Regional Outlook, 2023 & 2030
FIG. 57 Global Stem Cells Market: Region Movement Analysis
FIG. 58 North America Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 59 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 60 Canada Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 61 Europe Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 62 Germany Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 63 UK Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 64 France Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 65 Italy Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 66 Spain Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 67 Denmark Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 68 Norway Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 69 Sweden Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 76 Thailand Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 77 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 78 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 79 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 80 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 81 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 82 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 83 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 84 UAE Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 85 Kuwait Stem Cells Market, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Global Stem Cells Market: Product Outlook (Revenue, USD Million, 2022 - 2030)
    • Adult Stem Cells (ASCs)
      • Hematopoietic
      • Mesenchymal
      • Neural
      • Epithelial/Skin
      • Others
    • Human Embryonic Stem Cells (HESCs)
    • Induced Pluripotent Stem Cells (iPSCs)
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market: Application Outlook (Revenue, USD Million, 2022 - 2030)
    • Regenerative Medicine
      • Neurology
      • Orthopedics
      • Oncology
      • Hematology
      • Cardiovascular and Myocardial Infraction
      • Injuries
      • Diabetes
      • Liver Disorder
      • Incontinence
      • Others
    • Drug Discovery and Development
  • Global Stem Cells Market: Technology Outlook (Revenue, USD Million, 2022 - 2030)
    • Cell Acquisition
      • Bone Marrow Harvest
      • Umbilical Blood Cord
      • Apheresis
    • Cell Production
      • Therapeutic Cloning
      • In-vitro Fertilization
      • Cell Culture
      • Isolation
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market: Therapy Outlook (Revenue, USD Million, 2022 - 2030)
    • Autologous
    • Allogenic
  • Global Stem Cells Market: Therapy Outlook (Revenue, USD Million, 2022 - 2030)
    • Pharmaceutical and Biotechnology Companies
    • Hospitals & Cell Banks
    • Academic & Research Institutes
  • Stem Cells: Regional Outlook (Revenue, USD Million, 2022 - 2030)
    • North America
      • North America Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • North America Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • North America Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • North America Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • North America Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • U.S.
        • U.S. Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • U.S. Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • U.S. Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • U.S. Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • U.S. Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Canada
        • Canada Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Canada Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Canada Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Canada Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Canada Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Europe
      • Europe Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Europe Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Europe Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Europe Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Europe Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Others
      • Germany
        • Germany Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Germany Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Germany Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Germany Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Germany Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • U.K.
        • U.K. Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • U.K. Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • U.K. Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • U.K. Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • U.K. Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • France
        • France Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • France Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • France Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • France Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • France Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Spain
        • Spain Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Spain Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Spain Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Spain Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Spain Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Italy
        • Italy Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Italy Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Italy Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Italy Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Italy Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Denmark
        • Denmark Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Denmark Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Denmark Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Denmark Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Denmark Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Sweden
        • Sweden Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Sweden Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Sweden Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Sweden Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Sweden Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Norway
        • Norway Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Norway Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Norway Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Norway Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Norway Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Asia Pacific
      • Asia Pacific Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Asia Pacific Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Asia Pacific Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Asia Pacific Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Asia Pacific Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • China
        • China Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • China Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • China Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • China Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • China Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Japan
        • Japan Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Japan Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Japan Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Japan Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Japan Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Others
      • India
        • India Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • India Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • India Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • India Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • India Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • South Korea
        • South Korea Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • South Korea Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • South Korea Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • South Korea Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • South Korea Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Australia
        • Australia Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Australia Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Australia Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Australia Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Australia Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Thailand
        • Thailand Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Thailand Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Thailand Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Thailand Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Thailand Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Latin America
      • Latin America Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Latin America Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Latin America Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Latin America Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Latin America Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • Brazil
        • Brazil Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Brazil Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Brazil Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Brazil Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Brazil Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Mexico
        • Mexico Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Mexico Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Mexico Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Mexico Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Mexico Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Argentina
        • Argentina Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Argentina Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Argentina Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Argentina Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Argentina Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Middle East & Africa
      • Middle East & Africa Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Middle East & Africa Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Middle East & Africa Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Middle East & Africa Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Middle East & Africa Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • South Africa
        • South Africa Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • South Africa Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • South Africa Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • South Africa Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • South Africa Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Saudi Arabia
        • Saudi Arabia Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Saudi Arabia Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Saudi Arabia Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Saudi Arabia Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Saudi Arabia Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • UAE
        • UAE Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • UAE Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • UAE Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • UAE Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • UAE Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Kuwait
        • Kuwait Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Kuwait Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Kuwait Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Kuwait Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Kuwait Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes

Stem Cells Market Dynamics

Drivers: Ongoing Developments In Regenerative Medicine

Growing demand for regenerative medicines is expected to propel the market for stem cells. Regenerative medicines have extensive applications in the treatment of various medical conditions such as Parkinson's, Crohn's diseases, cardiovascular tissue repair, skin wounds, and organ transplants. It is widely used in fields such as neurology, oncology, hepatology, diabetes, injuries, hematology, and orthopedics. In addition, the growing geriatric population and increasing demand for regenerative medicines for the early detection & prevention of diseases are some of the factors contributing to market growth. Regenerative medicines help in restoring the normal functioning of cells. The introduction of novel tools and solutions that are accurate and can be used conveniently has led to the development of pioneering technologies leading to advancements in the field of regenerative medicine. The field of regenerative medicine is witnessing continuous developments, and products have found use in several therapeutic applications.

Rising Funds For Accelerating Stem Cell Research

The stem cell industry is expected to grow significantly over the forecast period due to an increase in healthcare expenditure in developed countries and improvisation in healthcare facilities in developing countries. Government initiatives such as the Patient Protection and Affordable Care Act (ACA) and increased access to healthcare facilities are some of the factors responsible for the growth of this market in developed countries. Robust funding to biotechnology companies is expected to boost the stem cell market owing to the use of different biotechnological kits and products in cell development, collection, characterization, and storage processes in stem cell banking. Furthermore, the market is also expected to grow as a consequence of extensive applications in different fields such as gene therapy, drug discovery, and personalized medicine. In addition, over the recent years, various organizations have come forward to fund stem cell centers and entities, further encouraging research activities performed to unlock the potential of stem cells in therapeutics.

Restraints: Ethical Concerns Related To Stem Cell Research

Research on human embryonic stem cells creates a moral dilemma. It involves choosing between human life and the prevention of suffering. Harvesting of embryonic stem cells involves the destruction of the human embryo, which raises a moral concern. In addition, stringent regulations for obtaining Intellectual Property Rights for products or materials used in research are major restraints for the commercialization of such services. Ethical approval should be obtained for the storage of cell lines and tissues in biorepositories to avoid the usage of tissue for an illegal purpose or for proxy identification of diseases to claim insurance. Moreover, controversies surrounding the use of embryonic stem cells for research and prognosis are restraining the market growth in several regions.

What Does This Report Include?

This section will provide insights into the contents included in this stem cells market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Stem cells market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Stem cells market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the stem cells market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for stem cells market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of stem cells market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Stem Cells Market Categorization:

The stem cells market was categorized into six segments, namely product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), application (Regenerative Medicine, Drug Discovery And Development), technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion And Sub-Culture), therapy (Autologous, Allogenic), end-use (Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The stem cells market was segmented into product, application, technology, therapy, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The stem cells market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Stem cells market companies & financials:

The stem cells market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • PLURISTEM THERAPEUTICS, INC., Pluristem Therapeutics, Inc. is a clinical-stage company involved in the development of cell therapies. It uses its proprietary 3D technology and placental cells to develop therapies. The company focuses on conditions such as hematological disorders, inflammations, ischemia, or radiation exposure. The company is involved in the development of therapies for acute radiation syndrome, recovery after surgery for femoral neck fracture, and critical limb ischemia. The U.S. FDA along with Japanese, European, and Israeli regulatory authorities have approved the production of PLX-PAD for late-stage trials at their manufacturing facilities and its marketing.

  • STEMCELL TECHNOLOGIES, INC., STEMCELL Technologies, Inc. is involved in the development and supply of systems, products, and accessories for life science research. Products offered by the company include cell culture media and cell separation products. These products have applications in various research fields, including neuroscience, hematology, stem cells, immunology, epithelial cell biology, and mesenchymal cells. It also offers instruments, antibodies, cytokines, contract assay, and proficiency testing services. The company operates in over 80 countries around the world, serving research tools for embryonic cells, neural stem cells, hematopoietic stem cells, induced pluripotent stem cells, and other types of cells. It was founded in 1993 and is headquartered in Vancouver, Canada.

  • THE BRISTOL-MYERS SQUIBB COMPANY, The Bristol-Myers Squibb Company, a known biopharmaceutical company, has delivered innovative medicines to aid patients in prevailing over critical diseases. Many of the drugs that were developed helped lots of patients to fight against life-threatening diseases such as cardiovascular disease, cancer, hepatitis B, and HIV. In the last ten years, Bristol Myers has delivered around 15 new drug molecules of which four are biologics. The company recently entered the gene therapy field through collaboration with uniQure N.V for the development of novel gene-altering drugs for cardiovascular diseases. It was established in 1887 and is headquartered in New York, U.S.

  • LISATA THERAPEUTICS, Lisata Therapeutics is a biopharmaceutical company involved in developing cell therapies based on various technologies such as T regulatory cell and CD34 cell technology, particularly in autoimmune and cardiovascular diseases. The company is involved in creating awareness about cell therapies and their potential to assist in the healing the body. In September 2022, the company changed its corporate name from Caladrius Biosciences, Inc. to Lisata Therapeutics, which reflected its transformation into an immunotherapy company. It was established in 1980 and is headquartered in New Jersey, U.S.

  • CELLULAR ENGINEERING TECHNOLOGIES, Cellular Engineering Technologies is a biotechnology company that specializes in tissue engineering, stem cell research, regenerative & personalized medicine, development of cell-based assays, and cancer biology. It develops technologies for preclinical drug discovery. It also provides nonembryonic stem & ancillary cells, cell lines, and immunological cells of human donors. Furthermore, it researches stem cells isolated from human nonembryonic sources, including bone marrows, adipose tissues, umbilical cord blood, placentas, and Wharton's jellies. In addition, it offers preclinical & translational research that involves characterizing cancer cell & synthetic biomaterials. It develops a systems biology approach for the prediction and modeling of cellular & tissue responses to pharmacological stimuli, which evaluates and quantifies kinetic responses of intracellular metabolic activities. Their product portfolio includes bioelectrode cell-based assays for drug screening & discovery, cell proliferation monitoring, chemotherapeutic agent testing, cellular adhesion & spreading, G protein activation studies, barrier function analysis, functional receptor-mediated signaling, and bacterial & viral infection quantification.

  • LINEAGE CELL THERAPEUTICS, INC., Lineage Cell Therapeutics, Inc. (formerly known as BioTime Inc.,) engineers and provides solutions for chronic degenerative diseases by supplying healthy cells, tissues, & organs. It utilizes advancements in biomaterials, biologics, and lab-generated cells & tissues, along with stem cell biology. Asterias Biotherapeutics, Inc.; LifeMap Sciences; LifeMap Solutions; Ascendance Biotechnology; OrthoCyte Corporation; ReCyte Therapeutics, Inc.; OncoCyte Corporation; and Cell Cure Neurosciences Ltd. are subsidiaries of Lineage Cell Therapeutics. Cell Cure Neurosciences Ltd. was acquired by the company in 2010. It was established in 1990 and is headquartered in CA, U.S.

  • BRAINSTORM CELL LIMITED, BrainStorm Cell Limited is involved in the development of autologous stem cell therapies for the treatment of neurodegenerative disorders, including Multiple Sclerosis (MS), Parkinson's disease, and Lou Gehrig's disease (Amyotrophic Lateral Sclerosis [ALS]). The company has initiated various clinical and preclinical programs for various diseases such as ALS, progressive MS, and autism.

  • GILEAD SCIENCES, INC., Gilead Sciences, Inc. is a pharmaceutical company that provides a platform for the development of new therapeutics. The company offers a treatment regime for HIV infection, cancer, respiratory disease, liver disease, and cardiovascular disease. Gilead operates in more than 30 countries worldwide. The company's portfolio includes 23 approved and commercially available products, as well as some therapeutics products that are under clinical trials. Gilead acquired Kite Pharma for 12 billion USD in 2017.

  • PROMOCELL GMBH, PromoCell GmbH is a biotechnology company that offers a comprehensive portfolio of around 7,000 cell culture and cell biology products. Products of the company are used for diverse applications, such as cancer research, and immuno-oncology, diabetes, cardiovascular, & respiratory research. The company operates in more than 50 countries across different regions, including North America, Asia, and Europe. It was founded in 1990 and is headquartered in Heidelberg, Germany.

  • SARTORIUS CELLGENIX GMBH, Sartorius CellGenix GmbH is a leading provider of ancillary and raw materials for gene & cell therapy, along with regenerative medicine. The company designs, develops, and commercializes human cytokines, growth factors, & other recombinant cell culture components as per GMP quality. The products are distributed across the globe and their major users are academia & industry players in commercial manufacturing & clinical trials. The development of ATMP expanded its reach in the cell culture market and added regulatory expertise. The company was established in 1994 and is headquartered in Freiburg, Germany.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Stem Cells Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2019 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Stem Cells Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.